Back to search

Article

Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular docking

2022-02-02

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Nonalcoholic fatty liver disease (NAFLD) is a metabolic-related disease with its incidence increasing annually. Shugan Xiaozhi (SGXZ) decoction, a composite traditional Chinese medicinal prescription, was demonstrated to exert a therapeutic effect on NAFLD. However, the underlying mechanisms were incompletely elucidated. In this study, the potential bioactive in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6585143f-bc72-5191-a4dd-fcdc5564ba5f
DOI
10.21203/rs.3.rs-1294807/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular dockingDOI 10.21203/rs.3.rs-1294807/v1
Exploring the Mechanism of Danggui Shaoyao San in the treatment of Non-alcoholic Fatty Liver Disease: A Study based on Network Pharmacology and Molecular DockingSemantic proximity
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Network Pharmacology Reveals the Multiple Mechanisms of Xiaochaihu Decoction in the Treatment of Non-alcoholic Fatty Liver DiseaseSemantic proximity
Mechanisms of Yinchen combined with Huangbai against Non-alcoholic fatty liver disease based on Network pharmacology, Molecular docking and Molecular Dynamics SimulationsSemantic proximity
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validationSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacologySemantic proximity
The Therapeutic Potential of Chi Shao and Fu Zi in Acute-on-Chronic Liver Failure: Insights from Network Pharmacology and Animal StudiesSemantic proximity
Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.Semantic proximity
Exploring anti-nonalcoholic fatty liver disease mechanism of Gardeniae Fructus by combining an animal model with network pharmacology and molecular dockingSemantic proximity
Mechanism of Sanliangsan Lipid-Lowering in treating hyperlipidemia: insights from network pharmacology and molecular dockingSemantic proximity
Network Pharmacology Integrated Molecular Docking Reveals The Mechanism of Huanglian Wendan Decotion Against Metabolic SyndromeSemantic proximity
Select a neighboring publication to make it the new centre.